ACP
CYNA

Acuta Capital Partners’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Acuta Capital Partners’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-115,400
Closed -$1.93M – 81
2016
Q2 		$1.93M Sell
115,400
-475,130
-80% -$6.39M 0.93% 30
2016
Q1 		$7.03M Buy
590,530
+213,883
+57% +$2.86M 3.93% 8
2015
Q4 		$5.76M Buy
376,647
+63,123
+20% +$959K 2.75% 13
2015
Q3 		$5.07M Buy
313,524
+143,908
+85% +$2.34M 2.94% 8
2015
Q2 		$2.76M Buy
+169,616
New +$2.78M 1.71% 22

Other funds holding CYNA

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BHMP
Bardin Hill Management Partners New York $80.3M AUM 31.37% 1-Year Est. Return
CC
Coastland Capital Palo Alto, California $1.6B AUM 29.3% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Acuta Capital Partners's CYNA Position: Q3 2016 in Review

Acuta Capital Partners sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q3 2016, closing a stake of 115,400 shares — an estimated $1.93M sold.

Acuta Capital Partners first reported a position in CYNA in Q2 2015 and held it in 5 quarters. The position peaked at $7.03M in Q1 2016. 60 funds tracked by Wall St. Rank hold CYNA as of Q3 2016.

  • Acuta Capital Partners reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Acuta Capital Partners sold 115,400 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q3 2016, an estimated $1.93M.
  • Acuta Capital Partners first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 5 quarters.
  • Acuta Capital Partners's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $7.03M in Q1 2016.
  • 60 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q3 2016.

Based on Acuta Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.